Loading clinical trials...
Loading clinical trials...
Mucocutaneous leishmaniasis is endemic in the central region of Brazil and other countries worldwide. The standard treatment with meglumine antimoniate has a high rate of important adverse effects. Th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Brasilia
NCT00344188 · Leishmaniasis, Skin Diseases, Parasitic, and more
NCT07504757 · Leishmania Infantum Disease, Leishmaniasis, Visceral, and more
NCT06798402 · Cutaneous Leishmaniasis
NCT04268524 · Old World Cutaneous Leishmaniasis
NCT06793111 · Leishmaniasis, Visceral
Hospital Universitário de Brasília
Brasília, Federal District
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions